Professional Documents
Culture Documents
Ministry of AYUSH has launched the nationwide distribution campaign for poly-herbal formulation of
AYUSH64. Scientists have found that AYUSH 64 is useful in the treatment of asymptomatic, mild &
moderate COVID19 infection as an adjunct to standard care.
AYUSH-64 is an Ayurveda formulation, which was developed by the Central Council for in Ayurvedic
Sciences (CCRAS), the apex body for research in Ayurveda under the Ministry of AYUSH, for
management of Malaria. This drug was re-purposed as the ingredients showed notable antiviral,
immune-modulator and antipyretic properties.
The Ministry of AYUSH-Council of Scientific and Industrial Research (CSIR) collaboration has recently
completed a robust multi-centre clinical trial to evaluate the safety and efficacy of AYUSH 64 in the
management of mild to moderate COVID-19 patients.
AYUSH-64 is recommended in National Clinical Management Protocol based on Ayurveda and Yoga which is
vetted by National Task Force on COVID Management of ICMR and Guidelines for Ayurveda Practitioners for
COVID-19 Patients in Home Isolation.
In order to facilitate the manufacturers for their raw materials requirements NMPB has made a tentative list
of suppliers all over India which are as follows:
In case, these raw materials are available with other Medicinal Plants stakeholders they may write to
NMBP, email: - ayush64rawmaterial@gmail.com